Literature DB >> 33328589

PKBβ/AKT2 deficiency impacts brain mTOR signaling, prefrontal cortical physiology, hippocampal plasticity and select murine behaviors.

Sara Palumbo1,2, Clare Paterson1,3, Feng Yang1,4,5, Veronica L Hood3, Amanda J Law6,7,8,9.   

Abstract

The serine/threonine protein kinase v-AKT homologs (AKTs), are implicated in typical and atypical neurodevelopment. Akt isoforms Akt1, Akt2, and Akt3 have been extensively studied outside the brain where their actions have been found to be complementary, non-overlapping and often divergent. While the neurological functions of Akt1 and Akt3 isoforms have been investigated, the role for Akt2 remains underinvestigated. Neurobehavioral, electrophysiological, morphological and biochemical assessment of Akt2 heterozygous and knockout genetic deletion in mouse, reveals a novel role for Akt2 in axonal development, dendritic patterning and cell-intrinsic and neural circuit physiology of the hippocampus and prefrontal cortex. Akt2 loss-of-function increased anxiety-like phenotypes, impaired fear conditioned learning, social behaviors and discrimination memory. Reduced sensitivity to amphetamine was observed, supporting a role for Akt2 in regulating dopaminergic tone. Biochemical analyses revealed dysregulated brain mTOR and GSK3β signaling, consistent with observed learning and memory impairments. Rescue of cognitive impairments was achieved through pharmacological enhancement of PI3K/AKT signaling and PIK3CD inhibition. Together these data highlight a novel role for Akt2 in neurodevelopment, learning and memory and show that Akt2 is a critical and non-redundant regulator of mTOR activity in brain.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33328589      PMCID: PMC7854513          DOI: 10.1038/s41380-020-00964-4

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  65 in total

1.  Molecular cloning of a second form of rac protein kinase.

Authors:  P F Jones; T Jakubowicz; B A Hemmings
Journal:  Cell Regul       Date:  1991-12

2.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

3.  Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3.

Authors:  S Masure; B Haefner; J J Wesselink; E Hoefnagel; E Mortier; P Verhasselt; A Tuytelaars; R Gordon; A Richardson
Journal:  Eur J Biochem       Date:  1999-10-01

4.  Physiological regulation of Akt activity and stability.

Authors:  Yong Liao; Mien-Chie Hung
Journal:  Am J Transl Res       Date:  2010-01-01       Impact factor: 4.060

Review 5.  The activation of Akt/PKB signaling pathway and cell survival.

Authors:  Gang Song; Gaoliang Ouyang; Shideng Bao
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

6.  Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies.

Authors:  Bettina Dummler; Oliver Tschopp; Debby Hynx; Zhong-Zhou Yang; Stephan Dirnhofer; Brian A Hemmings
Journal:  Mol Cell Biol       Date:  2006-08-21       Impact factor: 4.272

7.  Regulation of neuronal survival by the serine-threonine protein kinase Akt.

Authors:  H Dudek; S R Datta; T F Franke; M J Birnbaum; R Yao; G M Cooper; R A Segal; D R Kaplan; M E Greenberg
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

8.  The Akt isoforms are present at distinct subcellular locations.

Authors:  Stacey A Santi; Hoyun Lee
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-16       Impact factor: 4.249

Review 9.  The AKT genes and their roles in various disorders.

Authors:  M Michael Cohen
Journal:  Am J Med Genet A       Date:  2013-09-03       Impact factor: 2.802

Review 10.  AKT/PKB signaling: navigating downstream.

Authors:  Brendan D Manning; Lewis C Cantley
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

View more
  6 in total

1.  Intermittent Theta Burst Stimulation Ameliorates Cognitive Deficit and Attenuates Neuroinflammation via PI3K/Akt/mTOR Signaling Pathway in Alzheimer's-Like Disease Model.

Authors:  Andjela Stekic; Milica Zeljkovic; Marina Zaric Kontic; Katarina Mihajlovic; Marija Adzic; Ivana Stevanovic; Milica Ninkovic; Ivana Grkovic; Tihomir V Ilic; Nadezda Nedeljkovic; Milorad Dragic
Journal:  Front Aging Neurosci       Date:  2022-05-17       Impact factor: 5.702

Review 2.  Reducing PDK1/Akt Activity: An Effective Therapeutic Target in the Treatment of Alzheimer's Disease.

Authors:  Shaobin Yang; Yaqin Du; Xiaoqian Zhao; Chendong Wu; Peng Yu
Journal:  Cells       Date:  2022-05-24       Impact factor: 7.666

Review 3.  Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review.

Authors:  Alina Wilkowska; Mariusz S Wiglusz; Katarzyna Jakuszkowiak-Wojten; Wiesław J Cubała
Journal:  Cells       Date:  2022-02-12       Impact factor: 6.600

Review 4.  Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression.

Authors:  Chen Xue; Ganglei Li; Juan Lu; Lanjuan Li
Journal:  Signal Transduct Target Ther       Date:  2021-11-24

5.  Anxiety and depression-like behaviours are more frequent in aged male mice conceived by ART compared with natural conception.

Authors:  Ning-Xin Qin; Yi-Ran Zhao; Wei-Hui Shi; Zhi-Yang Zhou; Ke-Xin Zou; Chuan-Jin Yu; Xia Liu; Ze-Han Dong; Yi-Ting Mao; Cheng-Liang Zhou; Jia-Le Yu; Xin-Mei Liu; Jian-Zhong Sheng; Guo-Lian Ding; Wen-Long Zhao; Yan-Ting Wu; He-Feng Huang
Journal:  Reproduction       Date:  2021-10-28       Impact factor: 3.906

6.  Utilizing network pharmacology and experimental validation to explore the potential molecular mechanisms of BanXia-YiYiRen in treating insomnia.

Authors:  Liang Wang; Peng Wang; Yingfan Chen; Chen Li; Xuelin Wang; Yin Zhang; Shaodan Li; Minghui Yang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.